# Lyell Immunopharma, Inc.: Unregistered equity sale (Form 8-K, 2026-11-04)

**Trigger Strength Score:** 45/100

| Field | Value |
|---|---|
| Company | Lyell Immunopharma, Inc. |
| Ticker | LYEL |
| CIK | 1806952 |
| Filed | 2026-11-04 |
| Event date | 2026-11-03 |
| Primary trigger | Unregistered equity sale |
| All items | 3.02 Unregistered equity sale |
| Location | South San Francisco, CA |
| SIC code | 2834 |
| Accession | 0001193125-26-446317 |

## Why this score
- Primary trigger: Unregistered equity sale.
- Filed in the last 3 days.

Source: SEC EDGAR Form 8-K current reports (https://www.sec.gov/Archives/edgar/data/1806952/000119312526446317/d158628d8k.htm). Last refreshed: 2026-11-05T20:39:29.618Z.
Event classification uses the item numbers companies report on Form 8-K; read the filing itself before acting. Informational only; not investment advice and not an offer or solicitation to buy or sell any security.